These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8557286)
1. Management of cardiac arrest survivors: drugs or devices. Madan N; Saksena S; Prakash A; Mathew PP Indian Heart J; 1995; 47(4):387-93. PubMed ID: 8557286 [No Abstract] [Full Text] [Related]
2. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)". Boriani G; Biffi M; Martignani C Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348 [No Abstract] [Full Text] [Related]
3. [Automatic defibrillator or anti-arrhythmia drugs for the therapy of patients who survived heart arrest or with syncopal ventricular arrhythmias? A critical analysis of the models relative to the studies in progress]. Cappato R; Kuck KH G Ital Cardiol; 1994 Dec; 24(12):1613-21. PubMed ID: 7883135 [No Abstract] [Full Text] [Related]
4. Randomized clinical trials: how long should they last? Wellens HJ Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514 [No Abstract] [Full Text] [Related]
5. Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomised assignment to implantable cardioverter defibrillator or antiarrhythmic drug therapy. Cappato R; Boczor S; Kuck KH; Eur Heart J; 2004 Apr; 25(8):642-9. PubMed ID: 15084368 [TBL] [Abstract][Full Text] [Related]
6. Regression methods for cost-effectiveness analysis with censored data. Willan AR; Lin DY; Manca A Stat Med; 2005 Jan; 24(1):131-45. PubMed ID: 15515137 [TBL] [Abstract][Full Text] [Related]
7. Management decisions in survivors of cardiac arrest. Smith W; McAlister H; Crozier I; Hood M; Easthope R; Low C N Z Med J; 1997 Feb; 110(1038):45-7. PubMed ID: 9076283 [No Abstract] [Full Text] [Related]
8. Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committee. Am J Cardiol; 1997 Mar; 79(5):661-3. PubMed ID: 9068527 [No Abstract] [Full Text] [Related]
9. Incremental net benefit in randomized clinical trials. Willan AR; Lin DY Stat Med; 2001 Jun; 20(11):1563-74. PubMed ID: 11391688 [TBL] [Abstract][Full Text] [Related]
10. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454 [TBL] [Abstract][Full Text] [Related]
11. Amiodarone versus lidocaine for shock-resistant ventricular fibrillation. Silfvast T; Pettilä V N Engl J Med; 2002 Aug; 347(5):368-70; author reply 368-70. PubMed ID: 12151479 [No Abstract] [Full Text] [Related]
12. Summaries for patients. Cost-effectiveness of implantable defibrillators versus the drug amiodarone to prevent abnormal heart rhythms after heart attack. Ann Intern Med; 2001 Nov; 135(10):S-56. PubMed ID: 11757494 [No Abstract] [Full Text] [Related]
13. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs]. Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989 [TBL] [Abstract][Full Text] [Related]
16. ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg. Siebels J; Cappato R; Rüppel R; Schneider MA; Kuck KH Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 2):552-8. PubMed ID: 7681956 [No Abstract] [Full Text] [Related]
17. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data. Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258 [TBL] [Abstract][Full Text] [Related]
19. Incremental net benefit in randomized clinical trials with quality-adjusted survival. Willan AR; Chen EB; Cook RJ; Lin DY Stat Med; 2003 Feb; 22(3):353-62. PubMed ID: 12529868 [TBL] [Abstract][Full Text] [Related]